Teaching Courses

Thrombolysis decisions in particular clinical situations
J. de Keyser, Belgium)
Botulinum toxin for spasticity after stroke: when to treat?
D. Werring, United Kingdom
Individual decision making in malignant MCA infarction and hemicraniectomy
E. Jüttler, Germany
Antidepressive therapy after stroke: when is it indicated?
V. Murray, Sweden

2 Stroke mimics
Chairs: C. Warlow, United Kingdom and P. Lyden, USA

Differential diagnoses of TIA and stroke
P. Lyden, USA
Uncommon TIA/stroke-mimics (HANDLE, posterior reversible encephalopathy)
H. Mattle, Switzerland
Functional paralysis
A. Carson, United Kingdom
Biomarkers – useful in stroke diagnosis?
C. Foerch, Germany

3 Heart and brain
Chairs: A. Chamorro, Spain and P. Pullicino, United Kingdom

Difficult decision making in patients with AF-associated stroke
A.Chamorro, Spain
Raised troponin-levels in acute stroke: what does it mean?
J. Jensen, Denmark
Should we look for coronary heart disease in stroke patients?
E. Touzé, France
Stroke and heart failure
A. Slowik, Poland

4 Stroke recurrence
Chairs: K. Asplund, Sweden and L. Goldstein, USA

Long term prognosis after TIA and stroke: how much can be prevented?
P. Amarenco, France
BP lowering after stroke: when to start, what to start, how much?
B. Carlberg, Sweden
Cholesterol lowering after stroke: when to start, what to start, how much?
L.Goldstein, USA
How do we make persons change life-style after stroke?
K. Asplund, Sweden

5 Translational basic science stroke research
Chairs: T. Wieloch, Sweden and U. Laufs, Germany

Novel in vitro models of the Neurovascular Unit
V. Berezowski, France
Mild hypothermia – neuroprotection that works
T. Wieloch, Sweden
Stroke prevention – new impulses in translational research
U. Laufs, Germany
Fundamentals of preclinical stroke research
T. Malm, Finland

---Break 30 minutes---

6 Stroke in young adults
Chairs: M. Brown, United Kingdom and J-L. Mas, France

Dissection
T. Brandt, Germany
PFO-update
J-L. Mas, France
Arterio-venous malformations
R. Al-Shahi Salman, United Kingdom
Obliterative intracranial disease
M. Brown, United Kingdom

7 Stroke and vision
Chairs: N. Bornstein, Israel and D. Kömpf, Germany

The retinal vessels as mirror of the brain vessels
N. Bornstein, Israel
Episodic loss of vision: diagnostic challenges
A. Kessler, Israel
Oculomotor disturbances
D. Kömpf, Germany
Cortical aspects of visual disturbances
M. Husain, United Kingdom

8 Primary prevention of stroke and vascular cognitive impairment
Chairs: P. Wester, Sweden and V. Hachinski, Canada

Primary stroke prevention: principles and players
C. Diener, Germany
The metabolic syndrome and diabetes as precursors of stroke
P. Wester, Sweden
Screening for atherosclerosis as surrrogate risk factors for stroke
P.Touboul, France
Vascular cognitive impairment and dementia: can it be prevented?
V. Hachinski, Canada

9 Stroke syndromes
Chairs: R. Kern, Germany and E. Carrera, Switzerland

Borderzone ischemia syndromes: hemodynamics, embolism, or both?
R.Kern, Germany)
Posterior cerebral artery syndromes
E. Carrera, Switzerland
Cerebral vasoconstriction syndromes
M. Zuber, France
Cerebellar stroke syndromes
E. Carrera, Switzerland

10 Stroke in the very old
Chairpersons G. Ford, United Kingdom and A. Lindgren, Sweden

Stroke in the very old: epidemiological and clinical overview
A.Lindgren, Sweden
Pharmacological aspects of stroke prevention in the elderly patient
G.Ford, United Kingdom
Stroke prevention in elderly patients with atrial fibrillation
O. Benavente, USA
Management of thrombolysis in elderly patients
A. Förster, Germany

Please note:
Professional Premium Members of the ESC and Members if the ESO are priviledged for booking TCs.

Participation at the Teaching Courses is free of charge. As spaces are limited, registration is, however, mandatory.
For all Teaching Courses, CME accreditation has been applied for at EACCME.